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(A) Anti-EGFR immunoprecipitates from A431 cells with or without EGF (50 ng/ml; 1 hr) stimulation were analyzed by western blotting using EGFR, MCM5, and MCM7 antibody.
(B) Anti-EGFR immunoprecipitates from A431 cells with or without EGF and/or 1 μM gefitinib treatment were analyzed by western blotting using EGFR, MCM5, and MCM7
antibody.
(C) Immunoprecipitates of endogenous MCM7 were analyzed by western blotting using with 20 ng/ml EGF, 10 g/ml insulin, 50 g/ml hydrocortisone, 100 ng/ml cholera toxin, 5%
horse serum, 100 units/ml penicillin, and 100 g/ml streptomycin.
In vitro kinase assay. For the Lyn and MCM7 in vitro kinase assay, the recombinant Lyn kinase and the 10 kinase assay buffer was obtained from Cell Signaling Technology Inc.
GST-MCM7 fusion proteins with either MCM7 or MCM7 Y600F mutant were then incubated with the purified Lyn kinase for kinase reaction. Lyn kinase (0.5 ng) was incubated at 30 °C for 10 min in 50 μl of kinase buffer in the presence of 0.1 mM ATP and 1 μg of the substrates. For EGFR and Lyn in vitro kinase assay, the recombinant EGFR kinase was obtained from sigma and the GST-p56 Lyn KD fusion proteins with either tyrosine or phenylalanine at residue 32 were then incubated with the purified EGFR kinase (20 ng) at MnCl 2 , 500 μM Na 3 VO 4 , and 25 mM DTT) in the presence of 0.1 mM ATP and 1 μg of the substrates. The reactions were then terminated and separated in 8% SDS-PAGE, followed by Coomassie blue staining or immunoblotting using 4G10 antibody to determine the relative tyrosine phosphorylation level.
Cell proliferation assay. Cells (1 x 10 4 ) were seeded in each well of the 6-well plates, and cell number was determined at the indicated time point using the Beckman Z1 Dual Cell and Particle Counter. Mass spectrometry. MCM7 and MCM7 interacting proteins were isolated by immunoprecipitation with a monoclonal antibody (Abcam) and separated by SDS-PAGE.
The protein bands corresponding to MCM7 and other MCM7-associated proteins were all excised and subjected to in-gel digestion with trypsin. Phosphopeptides were further purified using Phos-trap Enrichment Kit (PerkinElmer, Massachusetts, USA). MS/MS experiments were performed with an LTQ-FT ICR MS (Thermo Electron, California, USA) equipped with a nanoelectrospray ion source (New Objective, Massachusetts, USA). The analytic program was set at a linear gradient from 10% to 50% acetonitrile and a split flow rate of 300 nL/min. The top ten most abundant multiply charged ions were sequentially isolated for MS/MS by LTQ. Singly charged ions were rejected for MS/MS sequencing.
Immunohistochemical staining. The immunohistochemical staining of EGFR, phosphop56 Lyn Y32 and phospho-MCM7 Y600 was performed using a protocol described previously (Xia et al., 2004) . The following primary antibodies were used for staining: Mouse antiphospho-p56 Lyn Y32 (1:500); Mouse anti-phospho-MCM7 Y600 (1:1600); Rabbit anti-Lyn Chromatin Immunoprecipitation (ChIP). A431 cells were cultured in 10% FBS to ~75% confluence and then serum starved for overnight. After 7 hr EGF (50 ng/ml) stimulation,
